Effects of in vivo treatment with vasopressin and analogues on renal adenylate cyclase responsiveness to vasopressin stimulation in vitro.
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D003894:Deamino Arginine Vasopressin / Q000031:analogs & derivatives; D003919:Diabetes Insipidus / Q000201:enzymology / Q000235:genetics; D004231:Diuresis / Q000187:drug effects; D004789:Enzyme Activation; D005459:Fluorides; D005947:Glucose; D006150:Guanine Nucleotides; D006579:Heterozygote; D007668:Kidney / Q000187:drug effects / Q000201:enzymology*; D008236:Lypressin; D008297:Male; D051381:Rats; D013045:Species Specificity; D014667:Vasopressins / Q000031:analogs & derivatives*; D014869:Water Intoxication / Q000201:enzymology
D006150:Guanine Nucleotides; D014667:Vasopressins; D008236:Lypressin; D000262:Adenylyl Cyclases; D003894:Deamino Arginine Vasopressin; D005947:Glucose; D005459:Fluorides